No abstract available
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adolescent
-
Adult
-
Aged
-
Aged, 80 and over
-
Anidulafungin
-
Animals
-
Antifungal Agents* / adverse effects
-
Antifungal Agents* / pharmacokinetics
-
Antifungal Agents* / therapeutic use
-
Caspofungin
-
Child
-
Child, Preschool
-
Clinical Trials as Topic
-
Echinocandins
-
Fungal Proteins / adverse effects
-
Fungal Proteins / pharmacology
-
Fungal Proteins / therapeutic use
-
Humans
-
Infant
-
Infant, Newborn
-
Lipopeptides
-
Lipoproteins / adverse effects
-
Lipoproteins / pharmacology
-
Lipoproteins / therapeutic use
-
Micafungin
-
Middle Aged
-
Mycoses / drug therapy*
-
Mycoses / microbiology
-
Peptides, Cyclic / adverse effects
-
Peptides, Cyclic / pharmacokinetics
-
Peptides, Cyclic / pharmacology
-
Peptides, Cyclic / therapeutic use
-
Pyrimidines / adverse effects
-
Pyrimidines / pharmacokinetics
-
Pyrimidines / pharmacology
-
Pyrimidines / therapeutic use
-
Thiazoles / adverse effects
-
Thiazoles / pharmacology
-
Thiazoles / therapeutic use
-
Treatment Outcome
-
Triazoles / adverse effects
-
Triazoles / pharmacokinetics
-
Triazoles / pharmacology
-
Triazoles / therapeutic use
-
Voriconazole
Substances
-
Antifungal Agents
-
Echinocandins
-
Fungal Proteins
-
Lipopeptides
-
Lipoproteins
-
Peptides, Cyclic
-
Pyrimidines
-
Thiazoles
-
Triazoles
-
posaconazole
-
ER 30346
-
Anidulafungin
-
echinocandin B
-
Caspofungin
-
Voriconazole
-
Micafungin